Monrovia, Jan. 8 -- Health experts are urging swift regulatory approval for "Coartem Baby", a groundbreaking new malaria drug for infants under six months, warning delays could cost lives. Liberia continues to battle one of Africa's highest malaria burdens, with nearly one million cases and an estimated 3,500 deaths in 2023 - most among children under five, according to the WHO. Officials say U.S. funding cuts threaten progress toward eliminating malaria by 2030, as community health workers and hospitals struggle to manage severe infections without medicines.

DU-PORT ROAD, Paynesville - Aminata still remembers the heat of that morning in 2019-the way her six-month-old son's skin burned against her palm as she lifted him from the thin foa...